BioSpace News Archive

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

The global cell banking outsourcing market is likely to be driven by the rising demand for biopharmaceutical production targeting novel active sites, stem cell therapy, and gene therapy.

The global neonatal phototherapy devices market has tread along a healthy growth path in the recent years and continue to expand at a promising pace.

Reprocessing of medical devices indicate the way toward cleaning, investigating, testing, disinfecting, and bundling of utilized and terminated medical devices.

Cystoscopic surveillance recommended by urologists has become a mainstay in the management of urological disorders.

Gloves have become an indispensable part of surgeries for reducing the transfer of pathogens among operative team and to patients.

Dicerna Pharmaceuticals, Inc. announced that updated data related to RG6346, an investigational GalXC™ RNAi therapeutic for the treatment of chronic hepatitis B virus infection, will be presented at The Liver Meeting® Digital Experience™ 2020, hosted by the American Association for the Study of Liver Diseases, which will occur Nov. 13-16, 2020.

TaiGen Biotechnology Company, Limited announced that U.S. Food and Drug Administration has approved the Investigation New Drug application for TG-1000, a novel treatment for influenza A and B.

Samsung Biologics has entered into a strategic partnership with GeneQuantum Healthcare, a China biotech company, to jointly develop an antibody drug conjugate for the treatment of non-small-cell lung carcinoma, triple-negative breast cancer, and other solid tumors.

The evolving healthcare sector has raised its demand for a multitude of equipment. One such equipment is the medical cart, which is required for moving around medical supplies in a quick manner in a room or a given premise.